XSHE
000516
Market cap1.46bUSD
Oct 09, Last price
4.48CNY
1D
2.52%
1Q
9.27%
Name
XiAn International Medical Investment Co Ltd
Chart & performance
P/E
—
P/S
2.46
EPS
—
Div yield, %
—
Shrs. gr., 5y
3.01%
Rev. gr., 5y
20.45%
Revenues
4.07b
-15.39%
Net income
-313m
L+23.20%
CFO
1.28b
+26.49%
Dividend
Jun 28, 20190.08678 CNY/sh
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Xi'an International Medical Investment Company Limited, an organization headquartered in Xi'an, China, specializes in delivering a comprehensive range of medical services. The company achieves this through the management and operation of its various hospitals and medical centers. Established in 1956, the firm underwent a name change in January 2015, transitioning from its former designation, Xi'an Kaiyuan Investment Group Co., Ltd., to its present identity.
Key people
Jin Shi
Chairman of the Board · since 2015
Ruixuan Liu
President, Director · since 2015
Jian'an Cao
Vice Chairman of the Board · since 2025
Heling Cao
Vice Chairman of the Board · since 2009
Yaxing Wang
Chief Financial Officer · since 2018
Yikuan Sun
Vice President, General Manager - Investment Management Department · since 2021
Gao Wang
Vice President · since 2018
Zhen Ding
Vice President, Secretary of the Board · since 2021
Xu Liu
Vice Chairman of the Board · since 2012
Wenguo Sun
Vice President, Director · since 2012
Aiping Wang
Vice Chairman of the Board, Vice President · since 2025
Independent Director · since 2018
Independent Director · since 2021
Baotong Zhang
Independent Director · since 2021
Headquarters & legal address
陕西省西安市高新区团结南路16号保障楼5层
西安市, SN 100000
CN
西安市, SN 100000
CN
Valuation
Title CNY in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025‑12 | 2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | |
| Income | ||||||||||
Revenues | ||||||||||
Cost of revenue | ||||||||||
Unusual Expense (Income) | ||||||||||
NOPBT | ||||||||||
NOPBT Margin | ||||||||||
Operating Taxes | ||||||||||
Tax Rate | ||||||||||
NOPAT | ||||||||||
Net income | ||||||||||
Dividends | ||||||||||
Dividend yield | ||||||||||
Proceeds from repurchase of equity | ||||||||||
BB yield | ||||||||||
| Debt | ||||||||||
Debt current | ||||||||||
Long-term debt | ||||||||||
Deferred revenue | ||||||||||
Other long-term liabilities | ||||||||||
Net debt | ||||||||||
| Cash flow | ||||||||||
Cash from operating activities | ||||||||||
CAPEX | ||||||||||
Cash from investing activities | ||||||||||
Cash from financing activities | ||||||||||
FCF | ||||||||||
| Balance | ||||||||||
Cash | ||||||||||
Long term investments | ||||||||||
Excess cash | ||||||||||
Stockholders' equity | ||||||||||
Invested Capital | ||||||||||
ROIC | ||||||||||
ROCE | ||||||||||
| EV | ||||||||||
Common stock shares outstanding | ||||||||||
Price | ||||||||||
Market cap | ||||||||||
EV | ||||||||||
EBITDA | ||||||||||
EV/EBITDA | ||||||||||
Interest | ||||||||||
Interest/NOPBT | ||||||||||